Drug pricing spotlight: Wound care

As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value. 

Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.

This report shines a spotlight on:

• What’s driving the increased need for wound care.
• The potential effects of high-cost prescription wound dressings on patients and plan sponsors.
• How Optum Rx helps improve the quality of care while lowering costs.